手術部位感染（SSI）並不罕見，尤其是在特定高風險組別，包括脊柱畸形及腫瘤（即轉移性脊柱手術）手術。目前已採用廣受認可的措施以減少手術部位感染，而近年局部使用 Vancomycin 粉末亦日益普及。
適應症：Spinal Deformity、Trauma、Spinal Tumor、Surgical Site Infection
收案條件
納入條件
- Female or male adult with age ≥18 years
- Undergoing open posterior spinal surgery with instrumentation indicated for spinal deformity, trauma and tumor
- Able to understand the nature, scope and possible consequences of participation in the study
- Appropriate voluntary written informed consent have been provided by patients
排除條件
- Has been treated with antibiotics due to primary spinal infection (i.e. spondylodiscitis) within 1 year prior to surgery
- Ongoing treatment with antibiotics for other infections
- Undergoing minimally invasive surgery or anterior-only surgical approaches or deformity correction surgery for adolescent idiopathic scoliosis (inherent low-risk for surgical site infections18)
- Undergoing decompression-only surgery for cervical spine, spinal deformity, trauma and tumors
- Has known history of allergy to vancomycin, penicillin and other glycopeptides (teicoplanin)
- Has history of vancomycin resistance
- Pregnancy
收案條件維持 ClinicalTrials.gov 原始英文登錄資料，實際收案資格以研究團隊的正式評估與受試者同意書為準。資料來源：ClinicalTrials.gov，每兩週自動更新，最後同步：2026年10月8日。